Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$136,151,473
+$62,155,888 QoQ
Shares Held
1,187,333
+33.6% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#16
of 273 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. KYMR ranks #21 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in KYMR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,151,473 | 1,187,333 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $73,995,585 | 888,409 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $57,603,209 | 740,306 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $40,267,730 | 711,444 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,164,038 | 278,736 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,421,766 | 344,237 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $17,457,566 | 433,944 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $10,641,250 | 224,831 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,799,922 | 462,309 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,110,823 | 450,518 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $17,176,716 | 674,655 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,845,440 | 204,708 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $7,852,118 | 341,545 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $8,795,457 | 296,843 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $8,434,732 | 337,930 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $7,331,242 | 336,759 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $5,459,327 | 277,264 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $10,322,948 | 243,926 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $17,001,986 | 267,790 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $10,585,358 | 180,207 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,880,145 | 80,003 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $563,314 | 14,496 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,731,660 | 27,930 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,773,414 | 147,738 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||